![Svetlana Evans](https://profiles-cardiff.imgix.net/attachments/2443?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Svetlana Evans
Rheolwr Labordy
Cyhoeddiad
2021
2019
2018
2017
- Hakobyan, S., Luppe, S., Evans, D. R. S., Harding, K., Loveless, S., Robertson, N. P. and Morgan, B. P. 2017. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal 23(7), pp. 946-955., article number: 135245851666900. (10.1177/1352458516669002)
2016
2014
- Clark, S. J., Schmidt, C. Q., White, A. W., Hakobyan, S., Morgan, B. and Bishop, P. N. 2014. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. The Journal of Immunology 193(10), pp. 4962-4970. (10.4049/jimmunol.1401613)
- Ingram, G. et al. 2014. Complement activation in MS: An immunohistochemical analysis. Journal of Neurology, Neurosurgery & Psychiatry 85(10), pp. e4.13. (10.1136/jnnp-2014-309236.11)
2013
2012
- McCully, M. L., Ladell, K. I., Hakobyan, S., Mansel, R. E., Price, D. and Moser, B. 2012. Epidermis instructs skin homing receptor expression in human T cells. Blood 120(23), pp. 4591-4598. (10.1182/blood-2012-05-433037)
- Ingram, G. et al. 2012. Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Multiple Sclerosis Journal 18(10), pp. 1401-1411. (10.1177/1352458512438238)
- Gibson, J. et al. 2012. Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology 217(2), pp. 251-255. (10.1016/j.imbio.2011.07.015)
2011
2010
- Ingram, G. et al. 2010. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133(6), pp. 1602-1611. (10.1093/brain/awq085)
- Hakobyan, S., Tortajada, A., Harris, C. L., de Córdoba, S. R. and Morgan, B. P. 2010. Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney International 78(8), pp. 782-788. (10.1038/ki.2010.275)
- Ingram, G., Hakobyan, S., Robertson, N. and Morgan, B. P. 2010. Elevated plasma C4a levels in multiple sclerosis correlate with disease activity. Journal of Neuroimmunology 223(1-2), pp. 124-127. (10.1016/j.jneuroim.2010.03.014)
- Johnson, S. A. et al. 2010. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome - A pedigree revisited. Molecular Immunology 47(7-8), pp. 1585-1591. (10.1016/j.molimm.2009.12.001)
- Clark, S. J., Perveen, R., Hakobyan, S., Morgan, B. P., Sim, R. B., Bishop, P. N. and Day, A. J. 2010. Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina. Journal of Biological Chemistry 285(39), pp. 30192-30202. (10.1074/jbc.M110.103986)
2009
2008
Articles
- Wong, E. et al. 2021. C3 Glomerulopathy and related disorders in children. Clinical Journal of the American Society of Nephrology 16(11), pp. 1639-1651. (10.2215/CJN.00320121)
- Shimauchi, T. et al. 2019. Dendritic cells promote the spread of human T-cell leukemia virus type 1 via bidirectional interactions with CD4+ T cells. Journal of Investigative Dermatology 139(1), pp. 157-166. (10.1016/j.jid.2018.06.188)
- Loveless, S. et al. 2018. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis. Brain Pathology 28(4), pp. 507-520. (10.1111/bpa.12546)
- Hakobyan, S., Luppe, S., Evans, D. R. S., Harding, K., Loveless, S., Robertson, N. P. and Morgan, B. P. 2017. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal 23(7), pp. 946-955., article number: 135245851666900. (10.1177/1352458516669002)
- Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136(6), pp. 1172-1181. (10.1016/j.jid.2016.01.033)
- Clark, S. J., Schmidt, C. Q., White, A. W., Hakobyan, S., Morgan, B. and Bishop, P. N. 2014. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. The Journal of Immunology 193(10), pp. 4962-4970. (10.4049/jimmunol.1401613)
- Ingram, G. et al. 2014. Complement activation in MS: An immunohistochemical analysis. Journal of Neurology, Neurosurgery & Psychiatry 85(10), pp. e4.13. (10.1136/jnnp-2014-309236.11)
- Khandhadia, S. et al. 2013. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation. Ophthalmology 120(8), pp. 1612-1618. (10.1016/j.ophtha.2013.01.004)
- Goicoechea de Jorge, E. et al. 2013. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proceedings of the National Academy of Sciences of the United States of America 110(12), pp. 4685-4690. (10.1073/pnas.1219260110)
- Clark, S. J. et al. 2013. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. The Journal of Immunology 190(5), pp. 2049-2057. (10.4049/jimmunol.1201751)
- McCully, M. L., Ladell, K. I., Hakobyan, S., Mansel, R. E., Price, D. and Moser, B. 2012. Epidermis instructs skin homing receptor expression in human T cells. Blood 120(23), pp. 4591-4598. (10.1182/blood-2012-05-433037)
- Ingram, G. et al. 2012. Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Multiple Sclerosis Journal 18(10), pp. 1401-1411. (10.1177/1352458512438238)
- Gibson, J. et al. 2012. Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology 217(2), pp. 251-255. (10.1016/j.imbio.2011.07.015)
- Ingram, G., Hakobyan, S., Loveless, S., Robertson, N. and Morgan, B. P. 2011. Complement regulator factor H in multiple sclerosis. Journal of Cellular Biochemistry 112(10), pp. 2653-2654. (10.1002/jcb.23204)
- Ingram, G. et al. 2010. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133(6), pp. 1602-1611. (10.1093/brain/awq085)
- Hakobyan, S., Tortajada, A., Harris, C. L., de Córdoba, S. R. and Morgan, B. P. 2010. Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney International 78(8), pp. 782-788. (10.1038/ki.2010.275)
- Ingram, G., Hakobyan, S., Robertson, N. and Morgan, B. P. 2010. Elevated plasma C4a levels in multiple sclerosis correlate with disease activity. Journal of Neuroimmunology 223(1-2), pp. 124-127. (10.1016/j.jneuroim.2010.03.014)
- Johnson, S. A. et al. 2010. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome - A pedigree revisited. Molecular Immunology 47(7-8), pp. 1585-1591. (10.1016/j.molimm.2009.12.001)
- Clark, S. J., Perveen, R., Hakobyan, S., Morgan, B. P., Sim, R. B., Bishop, P. N. and Day, A. J. 2010. Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina. Journal of Biological Chemistry 285(39), pp. 30192-30202. (10.1074/jbc.M110.103986)
- Ingram, G., Hakobyan, S., Robertson, N. and Morgan, B. P. 2009. Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clinical and Experimental Immunology 155(2), pp. 128-139. (10.1111/j.1365-2249.2008.03830.x)
- Hakobyan, S. et al. 2008. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. Journal of Biological Chemistry 283(45), pp. 30451-30460. (10.1074/jbc.M803648200)
- Hakobyan, S. et al. 2008. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Investigative Ophthalmology and Visual Science 49(5), pp. 1983-1990. (10.1167/iovs.07-1523)